These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1759169)

  • 41. Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.
    Summers SA; Matijevic A; Almond MK
    Nephrol Dial Transplant; 2004 Aug; 19(8):2137-9. PubMed ID: 15252175
    [No Abstract]   [Full Text] [Related]  

  • 42. Concurrent presentation of erythrocytic and megakaryocytic aplasia.
    Canavan BF; Huhn RD; Kim HC; Kosmin M; Sheay W; Saidi P
    Am J Hematol; 1996 Jan; 51(1):68-72. PubMed ID: 8571940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C.
    Tanaka N; Ishida F; Tanaka E
    N Engl J Med; 2004 Mar; 350(12):1264-5. PubMed ID: 15028837
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary pure red cell aplasia.
    Agarwal AK; Yadav R; Jain A; Sangla KS; Arora V; Walia M
    J Indian Med Assoc; 1997 Feb; 95(2):53-4. PubMed ID: 9357245
    [No Abstract]   [Full Text] [Related]  

  • 45. [Aplastic anemia and pure red cell aplasia: diagnosis and treatment].
    Sawada K
    Rinsho Ketsueki; 2006 Mar; 47(3):176-89. PubMed ID: 16629482
    [No Abstract]   [Full Text] [Related]  

  • 46. Pure red cell aplasia and primary antiphospholipid syndrome: a unique association.
    Caldas CA; de Carvalho JF
    Rheumatol Int; 2012 May; 32(5):1363-5. PubMed ID: 20238220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
    Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
    Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation.
    Praditpornsilpa K; Buranasot S; Bhokaisuwan N; Avihingsanon Y; Pisitkul T; Kansanabuch T; Eiam-Ong S; Chusil S; Intarakumtornchai T; Tungsanga K
    Nephrol Dial Transplant; 2005 Mar; 20(3):626-30. PubMed ID: 15735244
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.
    Noutsias M; Pauschinger M; Poller WC; Schultheiss HP; Kühl U
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):37-51. PubMed ID: 15038412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pure red cell aplasia associated with dapsone therapy.
    Borrás-Blasco J; Conesa-García V; Navarro-Ruiz A; Devesa P; Matarredona J; Marín-Jiménez F
    Ann Pharmacother; 2005 Jun; 39(6):1137-8. PubMed ID: 15870135
    [No Abstract]   [Full Text] [Related]  

  • 51. Epoetin-induced pure red cell aplasia: diagnosis and treatment.
    Macdougall IC
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):585-8. PubMed ID: 18089975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pure red cell aplasia as an autoimmune-mediated disorder.
    Nara N
    Intern Med; 2002 Jul; 41(7):507-8. PubMed ID: 12132515
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immune modulation therapy in type I diabetes mellitus].
    Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
    Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
    [No Abstract]   [Full Text] [Related]  

  • 54. Successful treatment of tacrolimus-related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patient.
    Abongwa C; Abusin G; El-Sheikh A
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Successful treatment of idiopathic pure red cell aplasia with antithymocyte globulin].
    Soda M; Usuki K; Adachi Y; Kazama H; Iki S; Urabe A
    Rinsho Ketsueki; 2001 Nov; 42(11):1122-7. PubMed ID: 11808082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune-mediated pure red cell aplasia in renal transplant recipients.
    Zuber J; Beldjord K; Casadevall N; Thervet E; Legendre C; Varet B
    Haematologica; 2008 Nov; 93(11):1750-2. PubMed ID: 18790798
    [No Abstract]   [Full Text] [Related]  

  • 57. Azathioprine-induced pure red cell aplasia: case report and review.
    Agrawal A; Parrott NR; Riad HN; Augustine T
    Transplant Proc; 2004 Nov; 36(9):2689-91. PubMed ID: 15621125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pure red cell aplasia induced by erythropoiesis-stimulating agents.
    Pollock C; Johnson DW; Hörl WH; Rossert J; Casadevall N; Schellekens H; Delage R; De Francisco A; Macdougall I; Thorpe R; Toffelmire E
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):193-9. PubMed ID: 18178785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Azathioprine-associated pure red cell aplasia in renal transplant recipients: a report of two cases.
    Koduri PR; Vanajakshi S; Anuradha R
    Ann Hematol; 2014 Feb; 93(2):329-30. PubMed ID: 23680868
    [No Abstract]   [Full Text] [Related]  

  • 60. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.
    Mouthon L; Guillevin L; Tellier Z
    Autoimmun Rev; 2005 Jun; 4(5):264-9. PubMed ID: 15990072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.